PatientsVille.com Logo

Gastritis and Pantecta

PatientsVille

Gastritis Symptoms and Causes

Your stomach is an organ between your esophagus and small intestine. It is where digestion of protein begins. The stomach has three tasks. It stores swallowed food. It mixes the food with stomach acids. Then it sends the mixture on to the small intestine.

Most people have a problem with their stomach at one time or another. Indigestion and heartburn are common problems. You can relieve some stomach problems with over-the-counter medicines and lifestyle changes, such as avoiding fatty foods or eating more slowly. Other problems like peptic ulcers or GERD require medical attention.

You should see a doctor if you have any of the following:

  • Blood when you have a bowel movement
  • Severe abdominal pain
  • Heartburn not relieved by antacids
  • Unintended weight loss
  • Ongoing vomiting or diarrhea

NIH: National Institute of Diabetes and Digestive and Kidney Diseases

Check out the latest treatments for gastritis

gastritis treatment research studies

Pantecta clinical trials, surveys and public health registries


Find Drug Side Effect reports



Pantecta Side Effects

Death (23)
Gastrointestinal Haemorrhage (7)
Hiatus Hernia (6)
Haemorrhage (5)
Chest Discomfort (5)
Nausea (5)
Rib Fracture (5)
Osteoporosis (4)
Urticaria (4)
Wheezing (4)
Dengue Fever (3)
Bronchospasm (3)
Renal Failure (3)
Fall (3)
Neutropenia (2)
Ulcer (2)
Syncope (2)
Colon Cancer (2)
Anaemia (2)
Bone Densitometry (2)
Hepatic Failure (2)
Cardiac Failure (2)
Loss Of Consciousness (1)
Off Label Use (1)
Parotitis (1)
Myocardial Infarction (1)
Osteitis (1)
Neoplasm Malignant (1)
Myalgia (1)
Pallor (1)
Penile Ulceration (1)
Pruritus (1)
Pancreatic Carcinoma (1)
Metastasis (1)
Pain In Jaw (1)
Ovarian Cancer (1)
Agranulocytosis (1)
Bronchitis Bacterial (1)
Bronchopneumonia (1)
Anastomotic Leak (1)
Ocular Hyperaemia (1)
Dizziness (1)
Caesarean Section (1)
Cerebral Infarction (1)
Hernia Repair (1)
Hypoglycaemia (1)
Headache (1)
Hand Fracture (1)
Haemolytic Anaemia (1)
Metastases To Lung (1)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

I want to know if you can loose weight by using pantecta

Noticed that my liver got swollen after being on Pantecta for five days.

Recently diagnosed with emphysemna, 50% lung capacity and together with other medecines was prescribed this drug Pantecta. Reading all these reports of patients that dies after some months after taking this medicament made me afraid. I am 69 years of

Bad gastritis or abdominal pain; had to get into tub with hot shower on my belly;never had a worse experience or pain; thought I was going to die; malaise; moderate ear pain

Diarrea crónica y acentuación de gastritis. Tengo enfermedad de Caroli leve. Lo tomo todos los días antes de dormir.

Diarrea crónica. Acentuación de la gastritis. Padezco enfermedad de Caroli

Ganaton is a perfect antacid., Gastritis medicine. Pantoprazole with Itopride good combination. Dr. Prabhu Dayal Pareek, 3, Mahadev Nagar, Gandhi Path, Jaipur.

Gastritis side effeck from revelex

I am a 28 year old female who was diagnosed 3 years ago with a hiatal hernia, 9 stomach ulcers and constant gastritis. They put me on aciphex. I have been on it ever since as it is the only thing that stops the pain. Just recently (within the

I am weak all over. I am peeing once every hour. I have blurry vision. The gastritis is killing me. I take Benicar 40/25 but I am going to the doctor today because of the weakness. Also will not be taking my pill today.

I have been taking prasugrel for 17 days 10mg as an alternative to aspirin and clopidogrel which I cannot tolerate even with ppi. both cause gastritis. for the past 2 days I have noticed gastritis again. I weigh 130lb and am 72. Should i reduce to 5m

I have had terrible crushing type pain between my ribs (upper abdo) just near the sternum.... and feel like I need to be sick, but nothing comes up..... the pain is unbearable. Doctors told me that it was gastritis, but this is th

I have taken Prednisone for severe asthma on many occassions (including IV in hospital for 7 days) and suffered severe abdominal pain. Three years ago a gastroscopy revealed I had Duodenal ulcers and Gastritis, most likely caused from the Prednisilo

Gastritis Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Esomeprazole Treatment for Patients With Lymphocytic Gastritis
Condition: Lymphocytic Gastritis
Intervention: Drug: Esomeprazole
Outcome Measures: The primary objective is to assess the healing rate of;   patients with lymphocytic Gastritis irrespective of H. pylori status after treatment;   with esomeprazole 20 mg twice daily for 2 weeks.;   Secondary objective of the study are to evaluate the grade and activity of Gastritis before and after;   treatment according to updated Sydney classification, to assess the clinical GI symptoms at baseline and after 3 months;   and to evaluate influence of the H. pylori-Status
2 Unknown  Study of the Chinese Prescription Weiqi Decoction on Chronic Atrophic Gastritis
Condition: Gastritis
Intervention: Drug: Weiqi decotion
Outcome Measures: Symptoms and conditions of tongue and pulse,the gastroscopy and pathological change;   Indicates of liver and renal function
3 Recruiting A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034
Conditions: Acute Gastritis;   Chronic Gastritis
Interventions: Drug: DA-6034;   Drug: Rebamipide 300mg
Outcome Measures: The number of erosions comparing the before and after the administration. For example, if the number of the erosion is 0, the score is 1 (normal).;   The number of erosions diagnosed by the gastroscope;   The severity of the digestive symptoms (Scale of 1 to 5)
4 Not yet recruiting Gastropanel for Gastric Atrophy and Cancer Risk Assessment
Conditions: Gastritis, Atrophic;   Stomach Neoplasms
Interventions: Procedure: GastroPanel test;   Procedure: Gastroscopy
Outcome Measure: Sensitivity and Specificity of the GastroPanel test for the detection of AG
5 Unknown  The Revolutions of Helicobacter Pylori Infection, Bacterial Density, and Histological Features After Antrectomy
Conditions: Helicobacter Pylori Infection;   Peptic Ulcer;   Bile Reflux;   Gastritis
Intervention:
Outcome Measure:
6 Unknown  The Metabolic Contribution of the Human Microbiota to Resting Energy Expenditure
Condition: Gastritis
Intervention: Procedure: Resting Energy Expenditure examination
Outcome Measure:
7 Recruiting Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
Conditions: Helicobacter Pylori Infections;   Atrophic Gastritis;   Gastric Cancer
Intervention: Drug: Triple therapy
Outcome Measures: Gastric cancer mortality;   Gastric cancer incidence;   All-cause mortality;   Incidence of- and mortality from other medical conditions
8 Unknown  Activation and Recruitment of GIL During Hp Infection
Conditions: Helicobacter Gastritis;   Dyspepsia
Intervention:
Outcome Measure:
9 Recruiting Role of Statin on the Gastric Inflammation in Patients at High Risk of Gastric Cancer
Condition: Early Gastric Cancer or Gastric Adenoma
Interventions: Drug: Arm1: Statin;   Drug: Arm2: Placebo
Outcome Measure: Proportion of the patients with high-risk (III/IV) OLGA stages
10 Not yet recruiting Endofaster Test for Helicobacter Pylori Detection in Patients on Proton Pump Inhibitor Therapy
Condition: Helicobacter Infections
Interventions: Procedure: Gastroscopy;   Device: EndoFaster test;   Other: Clo test;   Other: Faecal Helicobacter pylori antigen
Outcome Measure: Diagnostic accuracy of the EndoFaster test in H. pylori diagnosis
11 Recruiting A Study Comparing Billroth II With Roux-en-Y Reconstruction for Gastric Cancer
Conditions: Gastric Cancer;   Stomach Cancer;   Gastrectomy
Intervention: Procedure: Roux-en-Y or Billroth II
Outcome Measures: The aim of this study is to compare Billroth II and Roux En Y reconstruction after radical distal subtotal gastrectomy for gastric cancer in terms of postoperative outcomes.;   Quality of life pre and post operatively will be compared between Billroth II and Roux En Y reconstruction after radical distal subtotal gastrectomy.;   Gastrointestinal symptoms assessment;   Assessing nutritional status;   Grading of Gastritis and/or esophagitis on endoscopy
12 Unknown  Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection
Conditions: Helicobacter Pylori Infection;   Chronic Gastritis
Interventions: Drug: esomeprazole;   Drug: moxifloxacin;   Drug: amoxicillin
Outcome Measures: Efficacy of a combination of esomeprazole (E), moxifloxacin (M) and amoxicillin (A) for third line therapy of H. pylori infection.;   Comparison of EMA 7 days versus EMA 14 days. Hypothesis: superiority of EMA 14 days 4 weeks after end of eradication therapy;   Tolerability,safety, post treatment resistance, influence of host genetics (CYP status) and pathogenicity factors of H. pylori on treatment success.
13 Unknown  Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection
Conditions: Helicobacter Infections;   Gastritis;   Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: rabeprazole, amoxicillin, clarithromycin, metronidazole
Outcome Measures: Which treatment yields the higher re-eradication rate of H. pylori infection;   Side effects
14 Unknown  Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori
Conditions: Helicobacter Infections;   Gastritis;   Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: Lansoprazole, clarithromycin, amoxicillin
Outcome Measures: Whether the tailored treatment yields a higher eradication rate in comparison with the standard treatment;   Cost-effectiveness of the tailored strategy
15 Recruiting Control of Helicobacter Pylori Infection by Probiotics
Condition: Helicobacter Pylori Infection
Interventions: Dietary Supplement: L. reuteri DSM 17938 and ATCC PTA 6475;   Other: Placebo
Outcome Measures: to decrease H. pylori gastric load;   To decrease dyspeptic symptoms
16 Recruiting High Dose PPI Triple Therapy Versus Sequential Therapy for Helicobacter Pylori Eradication
Conditions: Dyspepsia;   Helicobacter-associated Gastritis;   Stomach Disorders
Interventions: Drug: Double dose of PPI;   Drug: sequence of drug use
Outcome Measures: Eradication rate;   Adherence rate/adverse events;   Prevalence of clarithromycin resistance HP;   Symptomatic responses regarding dyspeptic symptoms after HP eradication
17 Recruiting Concomitant Therapy of H. Pylori
Condition: Gastritis, Gastric Ulcer, and Duodenal Ulcer
Intervention: Drug: amoxicillin, clarithromycin, metronidazole, rabeprazole
Outcome Measure: Evaluation of the efficacy of concomitant therapy for eradication of Helicobacter pylori
18 Recruiting HLA-DRB1 and HLA-DQB1 Genotyping for Autoantibody-positive and -Negative Patients With Atrophic Glossitis or Burning Mouth Syndrome
Condition: Atrophic Glossitis, Burning Mouth Syndrome
Intervention: Dietary Supplement: Supplementation of vitamin B complex, C, B12, folic acid, Iron and Zinic
Outcome Measures: Number of participants with finding the HLA-DRB1 and HLA-DQB1;   Number of participants with finding the HLA-DRB1-DQB1 haplotype
19 Recruiting Systematic Screening for Risk-factors for Ulcer Bleeding Before Anti-thrombotic Treatment
Conditions: Coronary Occlusion/Thrombosis;   Peptic Ulcer Hemorrhage
Intervention: Other: Screening for risk factors for ulcer bleeding
Outcome Measures: Admission for ulcer bleeding or haemorrhagic Gastritis;   Compliance with antithrombotic medicine;   Identification of patients with Benefit of Proton pump inhibitor Prophylaxis;   Gastrointestinal bleeding;   Uncomplicated ulcers;   Death;   Acute coronary syndrome
20 Not yet recruiting Rebamipide in Combination With Esomeprazole in the Management of Asian Patients With Functional Dyspepsia
Condition: Dyspepsia
Interventions: Drug: Rebamipide;   Drug: Placebo (for Esomeprazole);   Drug: Esomeprazole
Outcome Measures: Dyspepsia symptoms;   quality of life